An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

被引:0
作者
Danay Saavedra
Ana Laura Añé-Kourí
Naivy Sánchez
Lázaro Manuel Filgueira
Julio Betancourt
Carlos Herrera
Leniel Manso
Elibet Chávez
Armando Caballero
Carlos Hidalgo
Geydi Lorenzo
Meylan Cepeda
Carmen Valenzuela
Mayra Ramos
Kalet León
Zaima Mazorra
Tania Crombet
机构
[1] Department of Clinical Immunology. Center of Molecular Immunology,
[2] Biochemical Department. ICBP “Victoria de Girón”,undefined
[3] Manuel Piti Fajardo Universitary Hospital. Ciudad Escolar Abel Santamaría,undefined
[4] Arnaldo Milian Castro Universitary Hospital,undefined
[5] Cardiocentro “Ernesto Che Guevara”,undefined
来源
Immunity & Ageing | / 17卷
关键词
COVID-19; IL-6; Itolizumab; Cytokine release syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 82 条
[1]  
Fulop T(2018)The integration of inflammaging in age-related diseases Semin Immunol 40 17-35
[2]  
Witkowski JM(2018)Inflammaging Immunol Investig 478 770-773
[3]  
Olivieri F(2020)Allo-priming as a universal anti-viral vaccine: protecting elderly from current COVID-19 and any future unknown viral outbreak J Transl Med 181 196-1034
[4]  
Larbi A(2020)COVID-19: consider cytokine storm syndromes and immunosuppression Lancet 39510229 1033-10975
[5]  
Kirkwood KL(2020)Effective treatment of severe COVID-19 patients with tocilizumab Proc Natl Acad Sci U S A 11720 10970-402
[6]  
Har-Noy M(2017)Itolizumab, a novel anti-CD6 monoclonal antibody: a safe and efficacious biologic agent for management of psoriasis Expert Opin Biol Ther 173 395-130
[7]  
Or R(2010)CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction Clin Exp Immunol 1621 116-793
[8]  
Mehta P(2014)Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab MAbs 63 783-195
[9]  
McAuley DF(2016)Immunological evaluation of rheumatoid arthritis patients treated with itolizumab MAbs 81 187-539
[10]  
Brown M(2020)Can an effective SARS-CoV-2 vaccine be developed for the older population? Immun Ageing 17 8-474